Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Helbecque

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Neurology|May 9, 2001
VLDL receptor polymorphism, cognitive impairment, and dementiaN Helbecque, C Berr, D Cottel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humansN Helbecque, J Dallongeville, V Codron, et al.
Journal of Molecular Recognition : JMR|February 1, 1990
Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligandC Bailly, N Helbecque, J P Hénichart, et al.
Diabetes & Metabolism|October 13, 2007
Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetesR Gutierrez-Aguilar, Y Benmezroua, B Balkau, et al.
Diabetologia|April 15, 2005
Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesityF Vasseur, N Helbecque, S Lobbens, et al.
American Journal of Medical Genetics|May 9, 2001
Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population studyA Meirhaeghe, N Helbecque, D Cottel, et al.
Anti-Cancer Drug Design|June 1, 1989
Synthesis, biological activity and DNA interaction of anilinoacridine and bithiazole peptide derivatives related to the anti-tumor drugs m-AMSA and bleomycinE Morier-Teissier, C Bailly, J L Bernier, et al.
The American Journal of Cardiology|February 14, 1998
Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplastyM Hamon, C Amant, C Bauters, et al.
Neurogenetics|February 7, 2001
Is the LDL receptor-related protein involved in Alzheimer's disease?J C Lambert, M C Chartier-Harlin, D Cottel, et al.
Journal of the American College of Cardiology|March 1, 1997
The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstrictionC Amant, M Hamon, C Bauters, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Neurology|May 9, 2001
VLDL receptor polymorphism, cognitive impairment, and dementiaN Helbecque, C Berr, D Cottel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humansN Helbecque, J Dallongeville, V Codron, et al.
Journal of Molecular Recognition : JMR|February 1, 1990
Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligandC Bailly, N Helbecque, J P Hénichart, et al.
Diabetes & Metabolism|October 13, 2007
Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetesR Gutierrez-Aguilar, Y Benmezroua, B Balkau, et al.
Diabetologia|April 15, 2005
Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesityF Vasseur, N Helbecque, S Lobbens, et al.
American Journal of Medical Genetics|May 9, 2001
Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population studyA Meirhaeghe, N Helbecque, D Cottel, et al.
Anti-Cancer Drug Design|June 1, 1989
Synthesis, biological activity and DNA interaction of anilinoacridine and bithiazole peptide derivatives related to the anti-tumor drugs m-AMSA and bleomycinE Morier-Teissier, C Bailly, J L Bernier, et al.
The American Journal of Cardiology|February 14, 1998
Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplastyM Hamon, C Amant, C Bauters, et al.
Neurogenetics|February 7, 2001
Is the LDL receptor-related protein involved in Alzheimer's disease?J C Lambert, M C Chartier-Harlin, D Cottel, et al.
Journal of the American College of Cardiology|March 1, 1997
The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstrictionC Amant, M Hamon, C Bauters, et al.
Pageof 7